Top 5 Canadian Stocks To Invest In 2023


What happened

Shares of Tilray (NASDAQ:TLRY) climbed on Wednesday after the Canadian cannabis company announced a deal with American marijuana retailer MedMen Enterprises (OTC:MMNFF). By the close of trading, Tilray’s stock price was up 1.1% after rising as much as 7.2% earlier in the day.

So what

Tilray agreed to purchase MedMen’s convertible notes from private equity firm Gotham Green Partners. The deal could position Tilray to quickly enter the U.S. market should federal legalization progress.

“Backed by accelerating trends toward legalization globally, we are focused on building the world’s leading cannabis-focused, consumer-branded company with a goal of $4 billion of revenue by the end of our fiscal 2024,” Tilray CEO Irwin Simon said in a press release. “The investment we are announcing in MedMen securities today, one of the most recognized brands in the $80 billion U.S. cannabis market, is a critical step toward delivering on our objective.”


Image source: Getty Images.

Top 5 Canadian Stocks To Invest In 2023: Canadian Imperial Bank of Commerce(CM)

Canadian Imperial Bank of Commerce provides various financial products, services, and advice to individual, small business, commercial, corporate, and institutional clients in Canada and internationally. The company offers retail markets services comprising personal banking, business banking, and wealth management services, as well as investment management services to retail and institutional clients. It also provides wholesale banking services, including credit, capital markets, investment banking, merchant banking, and research products and services to government, institutional, corporate, and retail clients. The company provides its services through its branch network, automated bank machines, mobile banking, and online banking site. As of June 3, 2011, it operated approximately 1,100 branches and 4,000 automated bank machines in Canada. The company was founded in 1867 and is headquartered in Toronto, Canada.


Advisors’ Opinion:

  • [By Ethan Ryder]

    Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) saw unusually large options trading activity on Monday. Traders acquired 2,517 call options on the stock. This is an increase of approximately 3,772% compared to the typical volume of 65 call options.

  • [By Motley Fool Transcribing]

    Canadian Imperial Bank of Commerce (NYSE:CM) Q1 2019 Earnings Conference CallFeb. 28, 2019 8:00 a.m. ET


    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Canadian Stocks To Invest In 2023: Transcananda Pipelines Ltd.(TRP)

Transcanada Corporation operates as an energy infrastructure company in North America. The company operates in three segments: Natural Gas Pipelines, Oil Pipelines, and Energy. The Natural Gas Pipelines segment develops and operates energy infrastructure, including natural gas pipelines and regulated gas storage facilities. Its network of natural gas pipelines extends approximately 60,000 km tapping into gas supply basins in North America. The Oil Pipelines segment operates Keystone crude oil pipeline system, which includes completed 3,467 km Wood River/Patoka and Cushing Extension phases, and the proposed 2,673 km U.S. Gulf Coast Expansion. The Energy segment engages in the acquisition, development, construction, ownership, and operation of electrical power generation plants; the purchase and marketing of electricity; the provision of electricity account services to energy and industrial customers; and the development, construction, ownership, and operation of non-regulat ed natural gas storage in Alberta. The company was founded in 1951 and is headquartered in Calgary, Canada.


Advisors’ Opinion:

  • [By ]

    Advisors Asset Management Inc. decreased its stake in shares of TC Energy Co. (NYSE:TRP) (TSE:TRP) by 7.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,118 shares of the pipeline company’s stock after selling 777 shares during the quarter. Advisors Asset Management Inc.’s holdings in TC Energy were worth $452,000 at the end of the most recent reporting period.

  • [By Matthew DiLallo]

    (NasdaqOTH: ANNSF)

    Industrials Spain Airports
    Enbridge (NYSE:ENB) Energy Canada Oil and natural-gas pipelines and natural-gas utilities
    NextEra Energy (NYSE:NEE) Utilities U.S.  Electric and natural gas utilities, wind- and solar-power generation
    Atlantia (NASDAQOTH:ATASY) Industrials Italy Toll roads and airports
    Duke Energy (NYSE:DUK) Utilities U.S.  Electric and natural gas utilities
    TransCanada (NYSE:TRP) Energy Canada Oil and natural gas pipelines
    Kinder Morgan (NYSE:KMI) Energy U.S.  Oil and natural gas pipelines
    Iberdrola (NASDAQOTH:IBDRY) Utilities Spain Electric and natural gas utilities
    Getlink (NASDAQOTH:GRPTF) Industrials France Railroads


    Data source: S&P Global.

  • [By Matthew DiLallo]

    TransCanada (NYSE:TRP) has a long history of growing shareholder value. Overall, the Canadian pipeline giant has increased its dividend in each of the past 19 years — including an 8.7% raise for 2019 — which has helped fuel 12% total annual returns over that time frame. As a result of that steady diet of dividend increases, TransCanada currently offers an attractive 4.7% yield.

Top 5 Canadian Stocks To Invest In 2023: Valeant Pharmaceuticals International Inc(VRX)


Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.


Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Valeant Pharmaceuticals Intl (VRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    Progenics’ first drug, Relistor for opioid-induced constipation, hasn’t been a big seller, but Valeant Pharmaceuticals (NYSE:VRX) has taken over marketing of the drug in return for a reliable royalty stream. This will allow Progenics to focus on Azedra’s potential launch and a prostate cancer imaging agent in late-stage development.

Top 5 Canadian Stocks To Invest In 2023: Chipotle Mexican Grill Inc.(CMG)


Chipotle Mexican Grill, Inc. develops and operates fast-casual, fresh Mexican food restaurants in the United States, Canada, and England. Its restaurants primarily offer burritos, tacos, burrito bowls, and salads. As of December 31, 2011, it operated 1,230 restaurants, which includes 1 ShopHouse Southeast Asian Kitchen. Chipotle Mexican Grill, Inc. was founded in 1993 and is based in Denver, Colorado.

Advisors’ Opinion:

  • [By ]

    Chipotle Mexican Grill, Inc. (NYSE:CMG) has earned an average rating of “Buy” from the thirty ratings firms that are presently covering the company, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $1,776.83.

  • [By ]

    But there's a lot more to Monday's rally than just a 2.4% gain in shares of Pfizer. More vaccines means less COVID, and less COVID means more travel and leisure, which is great news for a host of sectors. As people go out more, they'll want more products from Estee Lauder  (EL) – Get Report, for example, and they'll be eating out more at Chipotle Mexican Grill  (CMG) – Get Report.

Top 5 Canadian Stocks To Invest In 2023: Prestige Brand Holdings Inc.(PBH)


Prestige Brands Holdings, Inc., together with its subsidiaries, engages in marketing, selling, and distributing over-the-counter healthcare and household cleaning products primarily in North America. The company?s Over-The-Counter Healthcare segment offers a portfolio of OTC products under nine core OTC brands, including Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Dramamine motion sickness products, Efferdent and Effergrip denture products, Little Remedies pediatric healthcare products, Luden’s cough drops, PediaCare pediatric healthcare products, and The Doctor?s brand of oral care products. This segment also provides other significant brands that include Dermoplast first-aid products, Murine eye and ear care products, NasalCrom allergy relief product, New-Skin liquid bandage, and Wartner wart removers. Its Household Cleaning segment markets household cleaning products, such as abrasive and non-abrasive tub and tile cleaner, scrubb ing pads and sponges, dilutables, anti-bacterial hard surface spray for counter tops, and glass cleaners under the Comet, Chore Boy, and Spic and Span brands. Prestige Brands Holdings distributes its products through various retail channels, including drug, food, dollar, and club stores, as well as supermarkets and mass merchandisers. The company was founded in 1996 and is headquartered in Irvington, New York.


Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Prestige Consumer Healthcare Inc (NYSE:PBH) – Stock analysts at William Blair cut their Q4 2019 earnings estimates for shares of Prestige Consumer Healthcare in a report released on Thursday, February 7th. William Blair analyst J. Andersen now forecasts that the company will post earnings of $0.69 per share for the quarter, down from their previous forecast of $0.70. William Blair also issued estimates for Prestige Consumer Healthcare’s FY2020 earnings at $2.80 EPS.

  • [By Motley Fool Transcribers]

    Prestige Brands Holdings Inc  (NYSE:PBH)Q3 2019 Earnings Conference CallFeb. 07, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Shares of Prestige Brands Holdings, Inc. (NYSE:PBH) have been assigned a consensus recommendation of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $71.40.

Leave a Reply

Your email address will not be published.